<Anchor>
'Laguebrio', an edible treatment that prevents the aggravation of severe cases of Corona infection in the early stages, has received emergency approval from the Ministry of Food and Drug Safety.
This is the second time after Pax Lovid, and reporter Jeong Da-eun explains who the drug is and what to pay attention to.
<Reporter>
The reason for the emergency approval of MSD's oral treatment, LaGebrio, is to prevent the serious deterioration of patients who cannot use the existing treatment.
There are 23 kinds of ingredients that should not be eaten together with Pax Lovid, which is already in use.
Lagevrio has not yet been approved for concomitant use.
[Kang Seok-yeon/Director of the Ministry of Food and Drug Safety Drug Safety Director: Lagebrio capsules could be a treatment alternative for high-risk, mild or moderately ill patients who are difficult to use Beclouriju or Paxrovid...
.]
Severe preventive effect is lower than 30% level, 88% of Paxrovid.
Therefore, the target of administration is limited to those who cannot take Paxrovid.
Pregnant women and children and adolescents under the age of 18 should not take it as it may affect the fetus and growth.
Women who are planning to become pregnant should use contraception for four days after taking it and men for three months.
If lactating, she does not recommend breastfeeding for four days after the last dose.
Take 4 tablets twice a day, 40 tablets in total for 5 days.
The drug should be taken as soon as possible within 5 days of the onset of symptoms.
Side effects such as diarrhea and nausea were reported, but they were mild.
As the first quantity, 20,000 people came in, and they will be supplied to medical institutions this Saturday after going through customs procedures.
Pax Lovid also introduced an additional 44,000 servings today (24th), increasing the remaining supply to 105,000.